New Enterprise Associates related stories
All articles and analysis
VC-backed Clementia seeks up to $150 mln from public debutMontréal clinical-stage biopharmaceutical company Clementia Pharmaceuticals Inc has filed for an initial public offering in the United States, Reuters recently reported. The company is seeking as much as $150 million (US$115 million) from an offering of common shares on the Nasdaq Global Market. Founded in 2010, Clementia is developing treatments for patients suffering from debilitating bone and other diseases. It has raised north of US$90 million from venture capital investors, including BDC Capital, Janus Henderson Investors, OrbiMed Advisors and New Enterprise Associates.
Retinal gene therapy company Nightstar scores $45 mln Series CLondon-based Nightstar, a retinal gene therapy company, has closed $45 million in Series C financing. The backers were Wellington Management Company, Redmile Group, Syncona and New Enterprise Associates.
- Tintri pulls its IPO plans the night before its debut
Mountain View, California-based Tintri Inc, a provider of storage management solutions, pulled its IPO the night before its schedule debut on the Nasdaq exchange. The company was planning to raise $109 million in the offering by selling 8.7 million shares between $10.50 and $12.50 per share. Tintri had raised more than $260 million in funding from such backers as Lightspeed Venture Partners, New Enterprise Associates, Menlo Ventures, Insight Venture Partners and Silver Lake Kraftwerk.
- Swift Navigation raises $34 mln from NEA, Eclipse and First Round
Swift Navigation said it raised $34 million of Series B financing in a round led by New Enterprise Associates and joined by existing investors Eclipse and First Round Capital.
- VC-backed Mersana Therapeutics debuts IPO
Cambridge, Massachusetts-based biotech company Mersana Therapeutics has raised $75 million for its IPO after pricing its 5 million shares at $15 per share. The stock began trading June 28, 2017 on the NASDAQ under the ticker symbol "MRSN." JP Morgan, Cowen and Leerink Partners are the lead underwriters. Mersana's backers included Cormorant Asset Management, Arrowpoint Partners, Takeda Pharmaceutical Company Limited, New Enterprise Associates and Rock Springs Capital.
- Stayawhile inks $1.5 mln seed
Stayawhile, a network of furnished apartments, has raised $1.5 million in seed funding, according to a source at the firm. New Enterprise Associates led the round with participation from other investors that included FF Angel and Global Founders Capital.
- Drive.ai snaps up $50 mln Series B
Silicon Valley-based Drive.ai, a builder of artificial intelligence software for self-driving vehicles, has secured $50 million in Series B funding, according to a blog post. https://medium.com/@drive.ai/drive-ai-growth-and-acceleration-series-b-fcdf78cf9e3a New Enterprise Associates led the round with participation from other investors that included GGV. In addition to the funding, NEA's Carmen Chang and AI pioneer Andrew Ng to Drive.ai's board of directors.
- Cloudflare unveils $100 mln venture fund
San Francisco-based Cloudflare, an internet performance and security company, has launched an $100 million fund. The Cloudflare Developer Fund will invest in startups building applications on Cloudflare's apps platform. The fund's investors are New Enterprise Associates, Venrock and Pelion Venture Partners.
